American Shared Hospital Services heads into its Q1 2026 report with a CEO vacancy, a stock down 27% in a month, and a short interest spike that appeared out of nowhere — a combustible combination for a micro-cap trading at $1.33.
The catalyst that defines this week is leadership, not positioning. CEO Gary Delanois resigned effective April 27, with COO Craig Tagawa stepping in as interim chief. The 8-K landed on April 24 and immediately overshadowed everything else happening in the stock. AMS had already been under pressure after Q4 2025 results — filed March 31 — showed full-year sales falling to $12.55 million from $15.63 million a year earlier, and the company swinging to a net loss of $1.55 million against prior-year net income of $2.19 million. The stock dropped 25% the day those numbers hit, and another 24% over the following five sessions. A CEO exit barely four weeks later compounds an already difficult narrative.
Short interest tells an unusual story on its own terms. The estimated short position collapsed from a mid-April peak of roughly 120,800 shares — the highest in the 30-day window — to around 45,300 shares by April 28, a 62% weekly reduction. But in the weeks before mid-April, shares short were running near just 800–3,700. The entire episode looks less like sustained bear conviction and more like a short-lived burst of bearish activity around the earnings release and its aftermath. At 0.69% of the free float — per the FINRA fortnightly data showing 1,931 shares — the structural short position remains trivial. Borrow costs hover around 4.6% annualised, barely changed over the past month, and availability in the lending pool is loose. There is no squeeze dynamic and no sign of organised short-selling pressure.
The ORTEX short score of 34.6 tells a similar story: the mid-April spike pushed it briefly into the upper 40s, but it has since retreated. The score ranks in the 52nd percentile versus the broader universe — unremarkable. Ownership is heavily concentrated. Raymond Stachowiak holds 22% of shares; the Estate of Ernest A. Bates and The InterTech Group together hold another 18%. Dimensional, Vanguard, and a handful of quant shops account for most of the remaining institutional float. DRW Holdings added 50,481 shares in the most recent filing — a fresh position worth watching for a name this thinly traded. Renaissance Technologies trimmed slightly.
The March 31 earnings print delivered the clearest data point on how this stock behaves under stress: a 25% single-day fall and a further 24% decline over the subsequent five sessions. No analyst coverage is current enough to cite — the most recent price target on record dates to August 2025 — so there is no Street framework to anchor expectations for Q1. Enterprise value stands at roughly $32 million. With Q4 revenue running at $7.73 million quarterly, the valuation is thin but the losses are real, and the business is shrinking year over year.
The next confirmed event is the Q1 2026 earnings report, currently expected on May 12. With an interim CEO in the chair, no analyst estimates available, and the stock sitting near multi-year lows, that print is the only near-term reference point worth tracking.
See the live data behind this article on ORTEX.
Open AMS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
